Provided by Tiger Trade Technology Pte. Ltd.

Mineralys Therapeutics, Inc.

29.30
-1.2000-3.93%
Pre-market: 29.26-0.0400-0.14%08:09 EDT
Volume:763.76K
Turnover:22.66M
Market Cap:2.58B
PE:-6.70
High:30.57
Open:30.04
Low:29.20
Close:30.50
52wk High:47.65
52wk Low:22.30
Shares:88.16M
Float Shares:66.03M
Volume Ratio:0.44
T/O Rate:1.16%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.3763
EPS(LYR):-2.2900
ROE:-80.88%
ROA:-46.18%
PB:4.69
PE(LYR):-12.79

Loading ...

Mineralys Therapeutics Grants Inducement Equity Awards to New Hires Under 2025 Plan

Reuters
·
Jul 28

Mineralys Therapeutics Reports Inducement Awards Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Jul 28

Mineralys Chief Commercial Officer Eric Warren Disposes of $199,900 in Common Shares

Reuters
·
Jul 24

Mineralys CMO David Malcom Rodman Disposes of 416 Common Shares Worth $11,036.48

Reuters
·
Jul 21

Mineralys Therapeutics CMO David Malcom Rodman Disposes of USD 559,234 in Common Shares

Reuters
·
Jul 16

Mineralys CMO David Malcom Rodman Sells 2,171 Common Shares Worth $65,781.30

Reuters
·
Jul 11

Did Index Removal, ENDO 2026 Data and a $150M Raise Just Shift Mineralys Therapeutics' (MLYS) Investment Narrative?

Simply Wall St.
·
Jul 06

Have Insiders Sold Mineralys Therapeutics Shares Recently?

Simply Wall St.
·
Jul 03

Mineralys Therapeutics (MLYS) Left Key Russell Indexes, Is The Stock Still Below Fair Value?

Simply Wall St.
·
Jul 02

Mineralys CCO Eric Warren Disposes of 104,124 Common Shares for $2.7 Million

Reuters
·
Jul 01

Mineralys Therapeutics director Daphne Karydas sells 3,000 shares valued at $75,000

Reuters
·
Jun 18

Mineralys posts ENDO 2026 lorundrostat biomarker presentation on uncontrolled hypertension

Reuters
·
Jun 15

Mineralys Therapeutics presents late-breaking data on lorundrostat

TIPRANKS
·
Jun 15

Mineralys says lorundrostat reduces heart failure risk biomarkers in post hoc analysis of hypertension trials

Reuters
·
Jun 14

Mineralys CMO David Malcom Rodman disposes of common shares worth $203,512.74

Reuters
·
Jun 13

Mineralys Therapeutics to join Goldman Sachs Global Healthcare Conference fireside chat

Reuters
·
Jun 09

Mineralys Therapeutics to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference

GlobeNewswire
·
Jun 09

Analysts Offer Insights on Healthcare Companies: Veeva Systems (VEEV), Mineralys Therapeutics, Inc. (MLYS) and ArriVent BioPharma, Inc. (AVBP)

TIPRANKS
·
Jun 04

Mineralys Therapeutics falls -12.7%

TIPRANKS
·
Jun 03

Mineralys prices offering of 5.66M shares of common stock at $26.50

TIPRANKS
·
Jun 03